I. Introduction
Aortic valve disease affects 3% of the general population, making it the most common acquired heart valve disease in developed countries [1]. an aging population and a lack of effective medical therapies lead to a greater burden from this condition. in the U.S. alone, more than 50 000 surgical aortic valve replacements are performed every year [2]. an increase in the number of high-risk surgical patients with multiple comorbidities and a reluctance of patients to undergo conventional open heart surgery have been driving the development of transcatheter techniques.